2-241096063-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_182501.4(MTERF4):c.1081G>A(p.Asp361Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000855 in 1,613,254 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_182501.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MTERF4 | NM_182501.4 | c.1081G>A | p.Asp361Asn | missense_variant | 4/4 | ENST00000391980.7 | NP_872307.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MTERF4 | ENST00000391980.7 | c.1081G>A | p.Asp361Asn | missense_variant | 4/4 | 1 | NM_182501.4 | ENSP00000375840.2 |
Frequencies
GnomAD3 genomes AF: 0.0000988 AC: 15AN: 151810Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000440 AC: 11AN: 250126Hom.: 0 AF XY: 0.0000370 AC XY: 5AN XY: 135298
GnomAD4 exome AF: 0.0000842 AC: 123AN: 1461444Hom.: 0 Cov.: 31 AF XY: 0.0000674 AC XY: 49AN XY: 727048
GnomAD4 genome AF: 0.0000988 AC: 15AN: 151810Hom.: 0 Cov.: 32 AF XY: 0.0000539 AC XY: 4AN XY: 74156
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 28, 2023 | The c.1081G>A (p.D361N) alteration is located in exon 4 (coding exon 4) of the MTERF4 gene. This alteration results from a G to A substitution at nucleotide position 1081, causing the aspartic acid (D) at amino acid position 361 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at